Certain women with a particularly high risk of developing breast cancer ought to find magnetic resonance imaging (MRI) scans with their yearly mammogram, in accordance with a new American Cancer Society guideline. The two tests together provide doctors a better possibility of discovering breast cancer early in these women, when it is easier to treat and the possibility of survival is greatest.
MRI scans are more sensitive than mammograms, but they are more probable to demonstrate spots in the breast that may or may not be cancer as well. Frequently there is no means of knowing whether or not these spots are cancerous short of a follow-up biopsy or some other invasive process. That is why the test is not suggested for women with an average risk of breast cancer, the guideline states.
MRI is recognized to be more responsive in identifying breast cancers than mammography, with a 71 - 100 percent correctness compared to 16 - 40 percent accuracy for mammography. Consequently, yearly breast cancer screening for high-risk women now characteristically includes MRI together with mammography and a clinical breast exam.
Even though studies have been not in agreement, there comes into view to be an emerging agreement that the usage of hormone replacement therapy (HRT) raises the risk of breast cancer.
Preventive medications (chemoprevention) decrease breast cancer risk for women at high risk of developing the disease. Learn how these medications work plus related side effects and health risks.
If you're at high risk of breast cancer, you possibly will be able to recover your odds of staying cancer-free by taking selected medicines, a method recognized as chemoprevention or chemoprophylaxis.
The best-known alternatives are selective estrogen receptor modulators (SERMs) — tamoxifen and raloxifene (Evista). Both drugs have Food and Drug Administration (FDA) approval for the avoidance of breast cancer in high-risk women.
Tidak ada komentar:
Posting Komentar